References
- HanSClinical vaccine developmentClin Exp Vaccine Res20154465325648742
- SilinDSLyubomskaOVJirathitikalVOral vaccination: where we are?Expert Opin Drug Del20074323340
- MitragotriSLahannJPhysical approaches to biomaterial designNat Mater20098152319096389
- ShahPKChyuKYFredriksonGNNilssonJImmunomodulation of atherosclerosis with a vaccineNat Clin Pract Cardiovasc Med2005263964616306920
- SinghSYangGSchlunsKSAnthonySMSastryKJSublingual vaccination induces mucosal and systemic adaptive immunity for protection against lung tumor challengePLoS One20149e9000124599269
- HillemanMRVaccines in historic evolution and perspective: a narrative of vaccine discoveriesVaccine2000181436144710618541
- JosephAItskovitz-CooperNSamiraSA new intranasal influenza vaccine based on a novel polycationic lipid-ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in miceVaccine2006243990400616516356
- ZhuQTaltonJZhangGLarge intestine-targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infectionNat Med2012181291129622797811
- BelyakovIMHelZKelsallBMucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaquesNat Med200171320132611726972
- RagotCGarnotelEVedySDukoral, vaccin oral contre le choleraMed Trop (Mars)20066623723916924813
- MorozovaOVSashinaTAFominaSGNovikovaNAComparative characteristics of the VP7 and VP4 antigenic epitopes of the rotaviruses circulating in Russia (Nizhny Novgorod) and the Rotarix and RotaTeq vaccinesArch Virol20151601693170325944143
- GonzalezAMNguyenTVAzevedoMSAntibody responses to human rotavirus (HRV) in gnotobiotic pigs following a new prime/boost vaccine strategy using oral attenuated HRV priming and intranasal VP2/6 rotavirus-like particle (VLP) boosting with ISCOMClin Exp Immunol200413536137215008967
- TateJECurnsATCorteseMMBurden of acute gastroenteritis hospitalizations and emergency department visits in US children that is potentially preventable by rotavirus vaccination: a probe study using the now-withdrawn rotashield vaccinePediatrics200912374474919254997
- HuangLMChangPFLeePIImmunogenicity and safety of Haemophilus influenzae type b conjugate vaccine (HibTITER) and a combination vaccine of diphtheria, tetanus, pertussis and HibTITER (TETRAMUNE) in two-month-old infantsJ Microbiol Immunol Infect19983118018610496155
- CryzSJJrPatient compliance in the use of Vivotif Berna(R) vaccine, typhoid vaccine, live oral Ty21aJ Travel Med1998514179772310
- ChenWHGreenbergRNPasettiMFSafety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR, prepared from new master and working cell banksClin Vaccine Immunol201421667324173028
- HawkenJTroySBAdjuvants and inactivated polio vaccine: a systematic reviewVaccine2012306971697923041122
- LandaverdeMVenczelLde QuadrosCAPoliomyelitis outbreak caused by vaccine-derived virus in Haiti and the Dominican RepublicRev Panam Salud Publica20019272274 Spanish11418973
- PremanandBPrabakaranMKienerTKKwangJRecombinant baculovirus associated with bilosomes as an oral vaccine candidate against HEV71 infection in micePLoS One20138e5553623390538
- WackARappuoliRVaccinology at the beginning of the 21st centuryCurr Opin Immunol20051741141815950445
- ReedSGBertholetSColerRNFriedeMNew horizons in adjuvants for vaccine developmentTrends Immunol200930233219059004
- NazarianSGargariSLMRasooliIHasanniaSPiroozniaNA PLGA-encapsulated chimeric protein protects against adherence and toxicity of enterotoxigenic Escherichia coliMicrobiol Res201416920521223906742
- VajdyMSrivastavaIPoloJDonnellyJO’HaganDSinghMMucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccinesImmunol Cell Biol20048261762715550120
- ShakyaAKNandakumarKSApplications of polymeric adjuvants in studying autoimmune responses and vaccination against infectious diseasesJ R Soc Interface2013102012053623173193
- LisuloMMKapuluMCBandaRAdjuvant potential of low dose all-trans retinoic acid during oral typhoid vaccination in Zambian menClin Exp Immunol201417546847524237035
- UrataTArimoriKNakanoHModification of release rates of cyclosporin A from polyl(L-lactic acid) microspheres by fatty acid esters and in-vivo evaluation of the microspheresJ Control Release19995813314110053186
- DelgadoALavelleECHartshorneMDavisSSPLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systemsVaccine1999172927293810438065
- RoseFWernJEIngvarssonPTEngineering of a novel adjuvant based on lipid-polymer hybrid nanoparticles: a quality-by-design approachJ Control Release2015210485725957906
- KreuterJBergULiehlESolivaMSpeiserPPInfluence of the particle size on the adjuvant effect of particulate polymeric adjuvantsVaccine198641251293727758
- ChauvierreCManchandaRLabarreDVauthierCMardenMCLeclercLArtificial oxygen carrier based on polysaccharides-poly(alkylcyanoacrylates) nanoparticle templatesBiomaterials2010316069607420488532
- CorradinGGiudiceGDNovel adjuvants for vaccinesCurr Med Chem2005417
- EldridgeJHStaasJKMeulbroekJAMcGheeJRTiceTRGilleyRMBiodegradable microspheres as a vaccine delivery systemMol Immunol1991282872942017198
- AndersonJSmithBPUlrichJTVaccination of calves with a modified bacterin or oil-in-water emulsion containing alkali-detoxified Salmonella-typhimurium lipopolysaccharideAm J Vet Res1991525966012053731
- IgartuaMHernandezRMEsquisabelAGascónARCalvoMBPedrazJLEnhanced immune response after subcutaneous and oral immunization with biodegradable PLGA microspheresJ Control Release19985663739801430
- PrietoMJBDelieFFattalECharacterization of V3 BRU peptide-loaded small PLGA microspheres prepared by a (W(1)/O)W(2) emulsion solvent evaporation methodInt J Pharm1994111137145
- ChaicumpaWParairoJRNewRCImmunogenicity of liposome-associated oral cholera vaccine prepared from combined Vibrio-cholerae antigensAsian Pac J Allergy199088794
- NayakBPandaAKRayPRayARFormulation, characterization and evaluation of rotavirus encapsulated PLA and PLGA particles for oral vaccinationJ Microencapsul20092615416518608800
- PrimardCRochereauNLucianiETraffic of poly(lactic acid) nanoparticulate vaccine vehicle from intestinal mucus to sub-epithelial immune competent cellsBiomaterials2010316060606820471085
- KimSYDohHJAhnJSInduction of mucosal and systemic immune response by oral immunization with H. pylori lysates encapsulated in poly(D,L-lactide-co-glycolide) microparticlesVaccine19991760761610075169
- KimSYDohHJJangMHHaYJChungSIParkHJOral immunization with Helicobacter pylori-loaded poly(D, L-lactide-co-glycolide) nanoparticlesHelicobacter19994333910352085
- KotloffKLSzteinMBWassermanSSLosonskyGADiLorenzoSCWalkerRISafety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infectionInfect Immun2001693581359011349017
- JoshiVBGearySMSalemAKBiodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responsesHum Vaccines Immunother2013925842590
- GutierroIHernandezRMIgartuaMGascónARPedrazJLSize dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheresVaccine200221677712443664
- SamadiNAbbadessaADi StefanoAThe effect of lauryl capping group on protein release and degradation of poly(D,L-lactic-co-glycolic acid) particlesJ Control Release201317243644323751568
- CarcabosoAMHernandezRMIgartuaMRosasJEPatarroyoMEPedrazJLPotent, long lasting systemic antibody levels and mixed Th1/Th2 immune response after nasal immunization with malaria antigen loaded PLGA microparticlesVaccine2004221423143215063565
- JiangTSinghBLiHSTargeted oral delivery of BmpB vaccine using porous PLGA microparticles coated with M cell homing peptide-coupled chitosanBiomaterials2014352365237324342722
- MundargiRCBabuVRRangaswamyVNano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivativesJ Control Release200812519320918083265
- JainAKGoyalAKMishraNVaidyaBMangalSVyasSPPEG-PLA-PEG block copolymeric nanoparticles for oral immunization against hepatitis BInt J Pharm201038725326220005936
- ArturssonPEdmanPLaaksoTSjöholmICharacterization of polyacryl starch microparticles as carriers for proteins and drugsJ Pharm Sci198473150715136440978
- WikingssonLSjoholmIPolyacryl starch microparticles as adjuvant in oral immunisation, inducing mucosal and systemic immune responses in miceVaccine2002203355336312213405
- HeritagePLUnderdownBJBrookMAMcDermottMROral administration of polymer-grafted starch microparticles activates gut-associated lymphocytes and primes mice for a subsequent systemic antigen challengeVaccine199816201020079796058
- AllcockHRKwonSAn ionically cross-linkable polyphosphazene-poly[bis(carboxylatophenoxy)phosphazene] and its hydrogels and membranesMacromolecules1989227579
- PayneLGJenkinsSAWoodsALPoly[di(carboxylatophenoxy) phosphazene] (PCPP) is a potent immunoadjuvant for an influenza vaccineVaccine19981692989607015
- AndrianovAKMarinAChenJSynthesis, properties, and biological activity of poly[di(sodium carboxylatoethylphenoxy)phosphazene]Biomacromolecules2006739439916398541
- EngNFGarlapatiSGerdtsVBabiukLAMutwiriGKPCEP enhances IgA mucosal immune responses in mice following different immunization routes with influenza virus antigensJ Immune Based Ther Vaccines20108420735838
- HariyadiDMMaYWangYThe potential for production of freeze-dried oral vaccines using alginate hydrogel microspheres as protein carriersJ Drug Deliv Sci Tec201424178184
- BowersockTLShalabyWSWBlevinsWEPoly(methacrylic acid) hydrogels for rumen bypass and the delivery of oral vaccines to ruminantsAcs Sym Ser1994545214220
- WuQJGongCYShiSMannan loaded biodegradable and injectable thermosensitive PCL-PEG-PCL hydrogel for vaccine deliverySoft Mater201210472486
- JungTKammWBreitenbachAHungererKDHundtEKisselTTetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in micePharm Res20011835236011442276
- BegSSamadANazishIColloidal drug delivery systems in vaccine deliveryCurr Drug Targets20131412313723072326
- TomaliaDADendrimer researchScience199125212311232
- BoasUHeegaardPMDendrimers in drug researchChem Soc Rev200433436314737508
- NaharMDuttaTMurugesanSFunctional polymeric nanoparticles: an efficient and promising tool for active delivery of bioactivesCrit Rev Ther Drug Carrier Syst20062325931817341200
- ShahiwalaAVyasTKAmijiMMNanocarriers for systemic and mucosal vaccine deliveryRecent Pat Drug Deliv Formul200711919075870
- ChakrabortyCPalSDossGPWenZHLinCSNanoparticles as “smart” pharmaceutical deliveryFront Biosci (Landmark Ed)2013181030105023747865
- MisumiSMasuyamaMTakamuneNTargeted delivery of immunogen to primate M cells with tetragalloyl lysine dendrimerJ Immunol20091826061607019414757
- PrabakaranMMadhanSPrabhuNGengGYNewRKwangJReverse micelle-encapsulated recombinant baculovirus as an oral vaccine against H5N1 infection in miceAntivir Res20108618018720153776
- MarasiniNGiddamAKGhaffarKAMultilayer engineered nanoliposomes as a novel tool for oral delivery of lipopeptide-based vaccines against group A StreptococcusNanomedicine (Lond)2016111223123627077314
- ChildersNKMichalekSMPritchardDGMcGheeJRMucosal and systemic responses to an oral liposome-Streptococcus mutans carbohydrate vaccine in humansReg Immunol199032892962132755
- LiuJWuJWangBOral vaccination with a liposome-encapsulated influenza DNA vaccine protects mice against respiratory challenge infectionJ Med Virol20148688689424122866
- HamblinKAWongJPBlanchardJDAtkinsHSThe potential of liposome-encapsulated ciprofloxacin as a tularemia therapyFront Cell Infect Microbiol201447924995163
- DaiXYZhuangLHWangDDNuclear translocation and activation of YAP by hypoxia contributes to the chemoresistance of SN38 in hepatocellular carcinoma cellsOncotarget201676933694726771844
- ChildersNKDenysFRMcGeeNFMichalekSMUltrastructural study of liposome uptake by M cells of rat Peyer’s patch: an oral vaccine system for delivery of purified antigenReg Immunol199038162223559
- LinTSChuangCCHsuHLRole of amphotericin B upon enhancement of protective immunity elicited by oral administration with liposome-encapsulated-Japanese encephalitis virus nonstructural protein 1 (NS1) in miceMicrob Pathog201049677420412849
- OnuigboEBOkoreVCOfokansiKCPreliminary evaluation of the immunoenhancement potential of Newcastle disease vaccine formulated as a cationic liposomeAvian Pathol20124135536022834549
- ChengHCChangCYHsiehFIEffects of tremella-alginate-liposome encapsulation on oral delivery of inactivated H5N3 vaccineJ Microencapsul201128556120945970
- ClarkMABlairHLiangLBreyRNBraydenDHirstBHTargeting polymerised liposome vaccine carriers to intestinal M cellsVaccine20012020821711567766
- ShuklaAMishraVKesharwaniPBilosomes in the context of oral immunization: development, challenges and opportunitiesDrug Discovery Today201621688889927038539
- MannJFSShakirECarterKCMullenABAlexanderJFerroVALipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1/Th2 bias in the immune response and protection against infectionVaccine2009273643364919464545
- JainSIndulkarAHardeHAgrawalAKOral mucosal immunization using glucomannosylated bilosomesJ Biomed Nanotechnol20141093294724749389
- ShuklaAKatareOPSinghBVyasSPM-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomesInt J Pharm2010385475219835938
- ZhaoQFZhangQYueYInvestigation of 3D ordered macroporous carbon with different polymer coatings and their application as an oral vaccine carrierInt J Pharm201548723424125895720
- SuksamranTNgawhirunpatTRojanarataTMethylated N-(4-N,N-dimethylaminocinnamyl) chitosan-coated electrospray OVA-loaded microparticles for oral vaccinationInt J Pharm2013448192723524125
- ZhangLZengZZHuCHControlled and targeted release of antigens by intelligent shell for improving applicability of oral vaccinesBiomaterials20167730731926624805
- TurKMCh’ngHSEvaluation of possible mechanism(s) of bioadhesionInt J Pharm19981606174
- JoyappaDHKumarCABanumathiNReddyGRSuryanarayanaVVCalcium phosphate nanoparticle prepared with foot and mouth disease virus P1-3CD gene construct protects mice and guinea pigs against the challenge virusVet Microbiol2009139586619505774
- MercuriLPCarvalhoLVLimaFAOrdered mesoporous silica SBA-15: a new effective adjuvant to induce antibody responseSmall2006225425617193031
- UlmerJBDeWittCMChastainMEnhancement of DNA vaccine potency using conventional aluminum adjuvantsVaccine199918182810501231
- ZhangQZhaoQZhangYInvestigation of 3-D ordered materials with a high adsorption capacity for BSA and their potential application as an oral vaccine adjuvantJ Colloid Interface Sci201443411312125170604
- PantarottoDPartidosCDGraffRSynthesis, structural characterization, and immunological properties of carbon nanotubes functionalized with peptidesJ Am Chem Soc20031256160616412785847
- Werengowska-CiecwierzKWisniewskiMTerzykAPConscious changes of carbon nanotubes cytotoxicity by manipulation with selected nanofactorsAppl Biochem Biotech2015176730741
- WangTZouMJiangHJiZGaoPChengGSynthesis of a novel kind of carbon nanoparticle with large mesopores and macropores and its application as an oral vaccine adjuvantEur J Pharm Sci20114465365922064451
- SnookJDChessonCBPenicheAGPeptide nanofiber-CaCO3 composite microparticles as adjuvant-free oral vaccine delivery vehiclesJ Mater Chem B2016416401649
- CarvalhoLVRuizRDScaramuzziKImmunological parameters related to the adjuvant effect of the ordered mesoporous silica SBA-15Vaccine2010287829783620937318
- ZhaoDFengJHuoQTriblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom poresScience19982795485529438845
- WangTJiangHZhaoQWangSZouMChengGEnhanced mucosal and systemic immune responses obtained by porous silica nanoparticles used as an oral vaccine adjuvant: effect of silica architecture on immunological propertiesInt J Pharm201243635135822721849
- NetoBPDda MataALMLLopesMVPreparation and evaluation of chitosan-hydrophobic silica composite microspheres: role of hydrophobic silica in modifying their propertiesPowder Technol2014255109119
- MahdaviMMavandadnejadFYazdiMHOral administration of synthetic selenium nanoparticles induced robust Th1 cytokine pattern after HBs antigen vaccination in mouse modelJ Infect Public Health20171010210927026241
- SalminenSBouleyCBoutron-RuaultMCFunctional food science and gastrointestinal physiology and functionBrit J Nutr199880S147S1719849357
- LiuPSunYWangQSunYLiHDuanYIntracellular trafficking and cellular uptake mechanism of mPEG-PLGA-PLL and mPEG-PLGA-PLL-Gal nanoparticles for targeted delivery to hepatomasBiomaterials20143576077024148242
- OgueSTakahashiYOnishiHMachidaYPreparation of double liposomes and their efficiency as an oral vaccine carrierBiol Pharm Bull2006291223122816755021
- ZhuQThomsonCWRosenthalKLMcDermottMRCollinsSMGauldieJImmunization with adenovirus at the large intestinal mucosa as an effective vaccination strategy against sexually transmitted viral infectionMucosal Immunol20081788819079163
- ZhangLHuC-HChengS-XZhuoRXHyperbranched amphiphilic polymer with folate mediated targeting propertyColloids Surf B Biointerfaces20107942743320537873
- ZhangLFanYWuYInositol based non-viral vectors for transgene expression in human cervical carcinoma and hepatoma cell linesBiomaterials2014352039205024314555
- XingYYLiuWLiXKGuoLLvXXiTImmunogenicity characterization of the multi-epitope vaccine CTB-UE with chitosan-CpG as combination adjuvants against Helicobacter pyloriBiochem Biophys Res Commun201546226927425957472
- KostenTDomingoCOrsonFKinseyBVaccines against stimulants: cocaine and MABrit J Clin Pharmaco201477368374
- ZhangLHuCHChengSXZhuoRXPEI grafted hyperbranched polymers with polyglycerol as a core for gene deliveryColloid Surface B201076427433
- SinghBMaharjanSJiangTCombinatorial approach of antigen delivery using M cell-homing peptide and mucoadhesive vehicle to enhance the efficacy of oral vaccineMol Pharmaceut20151238163828
- YooMKKangSKChoiJHTargeted delivery of chitosan nanoparticles to Peyer’s patch using M cell-homing peptide selected by phage display techniqueBiomaterials2010317738774720656343
- StertmanLLundgrenESjoholmIStarch microparticles as a vaccine adjuvant: only uptake in Peyer’s patches decides the profile of the immune responseVaccine2006243661366816513226
- LebensMTerrinoniMKarlssonSLConstruction and preclinical evaluation of mmCT, a novel mutant cholera toxin adjuvant that can be efficiently produced in genetically manipulated Vibrio choleraeVaccine2016342121212826973069
- HardeHSiddhapuraKAgrawalAKJainSDivalent toxoids loaded stable chitosan-glucomannan nanoassemblies for efficient systemic, mucosal and cellular immunostimulatory response following oral administrationInt J Pharm201548729230425895719
- GuptaPNKhatriKGoyalAKMishraNVyasSPM-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis BJ Drug Target20071570171318041638
- NochiTYukiYMatsumuraAA novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responsesJ Exp Med20072042789279617984304
- RashidIMoireNHerautBDimier-PoissonIMévélecMNEnhancement of the protective efficacy of a ROP18 vaccine against chronic toxoplasmosis by nasal routeMed Microbiol Immunol2017206536227757545
- YinYQinTWangXLinJYuQYangQCpG DNA assists the whole inactivated H9N2 influenza virus in crossing the intestinal epithelial barriers via transepithelial uptake of dendritic cell dendritesMucosal Immunol2015879981425492476
- LeitnerWWYingHRestifoNPDNA and RNA-based vaccines: principles, progress and prospectsVaccine19991876577710580187
- LiYGTianFLGaoFSTangXSXiaCImmune responses generated by Lactobacillus as a carrier in DNA immunization against foot-and-mouth disease virusVaccine20072590291117028078
- ChenSCJonesDHFynanEFProtective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticlesJ Virol199872575757619621034
- FooksARSharpeSAShallcrossJACleggJCCranageMPInduction of immunity using oral DNA vaccines expressing the measles virus nucleocapsid proteinDev Biol20001046571
- GamazoCIracheJMNanostructures for Oral Vaccine DeliveryAlonsoMJCsabaNSNanostructured Biomaterials for Overcoming Biological BarriersCambridgeRSC Publishing201291113
- NegashTLimanMRautenschleinSMucosal application of cationic poly(D,L-lactide-co-glycolide) microparticles as carriers of DNA vaccine and adjuvants to protect chickens against infectious bursal diseaseVaccine2013313656366223777953
- ChuDSSchellingerJGShiJConvertineAJStaytonPSPunSHApplication of living free radical polymerization for nucleic acid deliveryAcc Chem Res2012451089109922242774
- UlmerJBMasonPWGeallARNA-based vaccinesVaccine2012304414441822546329
- ZhuJWangYHuangHUpregulation of KPNβ1 in gastric cancer cell promotes tumor cell proliferation and predicts poor prognosisTumour Biol20163766167226242264